SUNNYVALE, Calif., Jan. 23 /PRNewswire-FirstCall/ --
Scios Inc. (Nasdaq: SCIO) today announced that the Company will host a webcast
to discuss its fourth quarter and full year 2002 results on Thursday,
February 13, 2003, at 10:00 a.m. Eastern Standard Time.
To access the webcast, participants should go to the Scios website:
http://www.sciosinc.com. The webcast will be archived on the Scios site for one week
through February 20, 2003.
Scios Inc.
Scios is a biopharmaceutical company developing novel treatments for
cardiovascular and inflammatory disease. The Company's disease-based
technology platform integrates expertise in protein biology with computational
and medicinal chemistry to identify novel targets and rationally design small
molecule compounds for large markets with unmet medical needs.
Forward-Looking Safe Harbor Statement
This news release contains forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. We generally identify such forward-looking statements
using words like "estimate," "believe," "intend," "expect," "may," "should,"
"plan," "project," "contemplate," "anticipate" or similar statements.
Statements that are not historical facts are forward-looking statements based
on current assumptions that involve risks and uncertainties. These risks and
uncertainties may include the sales penetration and success of Natrecor, the
success of clinical trials of Natrecor and our pipeline products, including
SCIO-469 and inhibitors to TGF-beta, our ability to partner the development
and commercialization of our pipeline products and Natrecor (outside the U.S.
and Europe) with third parties on favorable terms, or at all, as well as other
risks detailed from time to time in the reports filed by Scios with the SEC,
including the Company's quarterly reports and annual report on Form 10-K.
Actual results, performance or achievements of Scios may differ significantly
from those described in these forward-looking statements. Scios disclaims any
intention or obligation to update or revise any financial projections or
forward-looking statements, whether as a result of new information, future
events or otherwise.
SOURCE Scios Inc.
 back to top
Related links:
http://www.sciosinc.com
CONTACT:
Suzanne Beveridge of Scios Inc.,
+1-408-616-2947 (media and investors); or media, Jim Weiss of
WeissCom Partners, Inc., +1-415-260-1274; or investors, Fern
Lazar or Sara Moorin of Lazar Partners Ltd. +1-212-867-1762, both
for Scios Inc.
|
